Assay ID | Title | Year | Journal | Article |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID404617 | Antiproliferative activity against human HT29 cells after 72 hrs | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID404609 | Inhibition of sheep brain tubulin polymerization | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID404611 | Antiproliferative activity against human A549 cells after 72 hrs | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID404608 | Cytotoxicity against human KB cells after 72 hrs | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID404613 | Antiproliferative activity against human MDA-MB-231 cells after 72 hrs | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID1673996 | Antiproliferative activity against human DU145 cells incubated for 72 hrs by WST assay | 2020 | Journal of medicinal chemistry, 10-08, Volume: 63, Issue:19
| Colchicine Alkaloids and Synthetic Analogues: Current Progress and Perspectives. |
AID1673997 | Antiproliferative activity against human PANC1 cells incubated for 72 hrs by WST assay | 2020 | Journal of medicinal chemistry, 10-08, Volume: 63, Issue:19
| Colchicine Alkaloids and Synthetic Analogues: Current Progress and Perspectives. |
AID404612 | Antiproliferative activity against human MDA-MB-435 cells after 72 hrs | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID404659 | Antitumor activity against human U87 tumor transplanted in chick chorio-allantoic membrane assessed as reduction of tumor volume at 100 uM after 4 days | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID404616 | Antiproliferative activity against human K562 cells after 72 hrs | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID404870 | Antiproliferative activity against human MCF7 cells after 72 hrs | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID404610 | Antiproliferative activity against mouse B16F10 cells after 72 hrs | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID404618 | Antiproliferative activity against human HCT116 cells after 72 hrs | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
AID404615 | Antiproliferative activity against mouse L1210 cells after 72 hrs | 2008 | Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
| New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |